我們已在上線! 進一步了解
DRTSW圖示

Alpha Tau Medical Warrant

2.68 USD
-0.31
10.37%
收盤時 已更新 10月16日 下午4:00 EDT
1天
-10.37%
5天
-25.56%
1個月
-35.58%
3個月
-9.46%
6個月
182.11%
今年迄今
624.32%
1年
814.68%
5年
446.94%
10年
446.94%
 

關於: Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as a localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company has active clinical programs targeting a range of different tumor types, such as head and neck cancer, pancreatic cancer, brain cancer, liver metastases, lung cancer, and prostate cancer. Geographically, it operates in Israel, United States, and Japan with the majority of the revenue generated from Israel.

員工: 121

新聞

正面
中性
負面
市場情緒 3個月
正面 0%
中性 0%
負面 0%

我們尚未收到任何關於DRTSW的最新新聞文章。

價格圖表採用Lightweight Charts™實作